Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)

BACKGROUND: ARTO trial was designed to evaluate the difference in terms of outcomes between patients affected by oligo metastatic castrate resistant prostate cancer (mCRPC) treated with Abiraterone acetate and randomized to receive or not SBRT on all sites of disease. Here, we present a preliminary...

Descripción completa

Detalles Bibliográficos
Autores principales: Francolini, Giulio, Detti, Beatrice, Di Cataldo, Vanessa, Garlatti, Pietro, Aquilano, Michele, Allegra, Andrea, Lucidi, Sara, Cerbai, Cecilia, Ciccone, Lucia Pia, Salvestrini, Viola, Stocchi, Giulia, Guerrieri, Barbara, Visani, Luca, Loi, Mauro, Desideri, Isacco, Mangoni, Monica, Meattini, Icro, Livi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Radiotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349091/
https://www.ncbi.nlm.nih.gov/pubmed/35763249
http://dx.doi.org/10.1007/s11547-022-01511-7

Ejemplares similares

Ejemplares similares